Clinical Trials Logo

Hyperlipoproteinemia Type 1 clinical trials

View clinical trials related to Hyperlipoproteinemia Type 1.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03360747 Completed - Clinical trials for Familial Chylomicronemia Syndrome

Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS)

Start date: December 21, 2017
Phase: Phase 2
Study type: Interventional

This is a single center, open-label study to evaluate the efficacy of AKCEA-ANGPTL3-LRx for reduction of triglyceride (TG) levels in participants with FCS.

NCT ID: NCT02658175 Completed - Clinical trials for Familial Chylomicronemia Syndrome

The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome

Start date: December 23, 2015
Phase: Phase 3
Study type: Interventional

An open-label study of volanesorsen (ISIS 304801) administered subcutaneously to participants with FCS.